Physician

Abid H Khan, M.D.

According to 2025 Medicare claims, Abid Khan, M.D. (NPI: 1326184524) practices nephrology in the Riverside-San Bernardino-Ontario, CA market, with the plurality of this provider's patient population coming from San Bernardino, CA. This provider's primary affiliated billing organization is ABID HAMEED KHAN MD PROFESSIONAL CORPORATION (NPI: 1518153733; TIN: 330847750) and primary practice location at 91762-1209.

Khan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 125 traditional Medicare patients, billed 1,881 HCPCS/CPT codes, and received $197,679 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 2,262 prescription claims across 215 beneficiaries totaling $377,418 in drug costs, led by Auryxia (Ferric Citrate). DME data shows 145 claims. Open Payments data shows 19 records totaling $524. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	194	2,482	$275,426
2016	169	2,539	$270,388
2017	157	2,036	$226,552
2018	148	1,803	$209,546
2019	155	1,612	$195,294
2020	144	1,435	$189,534
2021	139	1,437	$185,390
2022	123	1,419	$182,576
2023	135	1,866	$213,064
2024	125	1,881	$197,679

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	172	2,370	$343,178
2016	189	2,277	$356,446
2017	161	2,092	$388,761
2018	183	1,988	$337,649
2019	200	2,211	$378,267
2020	175	2,497	$512,120
2021	186	2,061	$452,599
2022	189	1,951	$398,811
2023	203	2,225	$466,375
2024	215	2,262	$377,418

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	60	$1,805
2016	N/R	13	$369
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	145	$3,172

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	42	358	$278
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	84	241	$94
76770	Complete ultrasound scan behind abdominal cavity	43	57	$84
81002	Urinalysis, manual test	86	256	$3
82962	Blood glucose (sugar) test performed by hand-held instrument	80	240	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Auryxia	Ferric Citrate	52	1,540	$71,413
Clinolipid	Fat Emulsion/Olive/Soy/Phospho	171	1,176	$46,032
Farxiga	Dapagliflozin Propanediol	59	2,444	$40,759
Lokelma	Sodium Zirconium Cyclosilicate	50	1,652	$36,981
Prosol	Parenteral Amino Acid 20% No.1	210	1,430	$33,247

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7518	Mycophenolic acid, oral, 180 mg	N	N/R	28	$1,554
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	38	$753
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	25	$452
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	35	$391
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	N	N/R	19	$22

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	19	$524	Ardelyx, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abid H. Khan, M.D.?

Tedicare shows public-source Medicare data for Abid H. Khan, M.D. (NPI 1326184524), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abid H. Khan, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Abid H. Khan, M.D.?

Abid H. Khan, M.D. is linked to ABID HAMEED KHAN MD PROFESSIONAL CORPORATION (billing NPI 1518153733) in the available physician profile data.

Does Abid H. Khan, M.D. have Open Payments data?

Abid H. Khan, M.D. has 19 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.